Use of Paromomycin for the Treatment of Cryptosporidiosis in Patients with AIDS

We read with interest the recent article by Fichtenbaum et al. on the use of paromomycin for the treatment of cryptosporidiosis in patients with AIDS. Our experiences with this agent also have been largely favorable, but long-term administration has often been required. We treated six AIDS patients...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical infectious diseases 1993-12, Vol.17 (6), p.1070-1071
Hauptverfasser: Wallace, Mark R., Nguyen, Minh-Thu, Newton, James A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1071
container_issue 6
container_start_page 1070
container_title Clinical infectious diseases
container_volume 17
creator Wallace, Mark R.
Nguyen, Minh-Thu
Newton, James A.
description We read with interest the recent article by Fichtenbaum et al. on the use of paromomycin for the treatment of cryptosporidiosis in patients with AIDS. Our experiences with this agent also have been largely favorable, but long-term administration has often been required. We treated six AIDS patients who had cryptosporidiosis; for four patients, diagnosis was made by examination of stool specimens, for two patients by biopsy of the small bowel.
doi_str_mv 10.1093/clinids/17.6.1070
format Article
fullrecord <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_16790872</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>4457523</jstor_id><sourcerecordid>4457523</sourcerecordid><originalsourceid>FETCH-LOGICAL-c386t-5c7c228466c3a121868b5d9540bc11e8fcb2b8cca1dd6773133c7962d77973f43</originalsourceid><addsrcrecordid>eNo9kE1LAzEQhoMoWqs_QFDYk7e1mc3mY4-lWisIVmxBvIRsNovRblOTFO2_N6Wlpxnmed85PAhdAb4DXJGBXtilbcIA-B1LF46PUA8o4TmjFRynHVORl4KIM3QewhfGAALTU3QqgAHhtIde5sFkrs2myrvOdRttl1nrfBY_TTbzRsXOLOM2MPKbVXRh5bxtrAs2ZCk5VdEmHrJfGz-z4dP92wU6adUimMv97KP5-GE2muTPL49Po-FzrolgMaea66IQJWOaKChAMFHTpqIlrjWAEa2ui1poraBpGOcECNG8YkXDecVJW5I-ut39XXn3szYhys4GbRYLtTRuHSQwXmHBixSEXVB7F4I3rVx52ym_kYDlVqLcS5TAJZNbialzs3--rjvTHBp7a4lf7_hXiM4fcFlSTguScL7DNkTzd8DKf0vGU19O3j_krCQjqF4_5Jj8A4Ofhww</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16790872</pqid></control><display><type>article</type><title>Use of Paromomycin for the Treatment of Cryptosporidiosis in Patients with AIDS</title><source>Jstor Complete Legacy</source><source>MEDLINE</source><source>Oxford University Press Journals Digital Archive Legacy</source><creator>Wallace, Mark R. ; Nguyen, Minh-Thu ; Newton, James A.</creator><creatorcontrib>Wallace, Mark R. ; Nguyen, Minh-Thu ; Newton, James A.</creatorcontrib><description>We read with interest the recent article by Fichtenbaum et al. on the use of paromomycin for the treatment of cryptosporidiosis in patients with AIDS. Our experiences with this agent also have been largely favorable, but long-term administration has often been required. We treated six AIDS patients who had cryptosporidiosis; for four patients, diagnosis was made by examination of stool specimens, for two patients by biopsy of the small bowel.</description><identifier>ISSN: 1058-4838</identifier><identifier>EISSN: 1537-6591</identifier><identifier>DOI: 10.1093/clinids/17.6.1070</identifier><identifier>PMID: 8161375</identifier><language>eng</language><publisher>United States: The University of Chicago Press</publisher><subject>AIDS ; AIDS-Related Opportunistic Infections - complications ; AIDS-Related Opportunistic Infections - drug therapy ; Correspondence ; Cryptosporidiosis ; Cryptosporidiosis - complications ; Cryptosporidiosis - drug therapy ; Diarrhea ; Humans ; Paromomycin - administration &amp; dosage ; Paromomycin - adverse effects ; Paromomycin - therapeutic use ; Vertigo - chemically induced ; Weight loss</subject><ispartof>Clinical infectious diseases, 1993-12, Vol.17 (6), p.1070-1071</ispartof><rights>Copyright 1993 The University of Chicago</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c386t-5c7c228466c3a121868b5d9540bc11e8fcb2b8cca1dd6773133c7962d77973f43</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/4457523$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/4457523$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,776,780,799,27903,27904,57995,58228</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8161375$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wallace, Mark R.</creatorcontrib><creatorcontrib>Nguyen, Minh-Thu</creatorcontrib><creatorcontrib>Newton, James A.</creatorcontrib><title>Use of Paromomycin for the Treatment of Cryptosporidiosis in Patients with AIDS</title><title>Clinical infectious diseases</title><addtitle>Clinical Infectious Diseases</addtitle><description>We read with interest the recent article by Fichtenbaum et al. on the use of paromomycin for the treatment of cryptosporidiosis in patients with AIDS. Our experiences with this agent also have been largely favorable, but long-term administration has often been required. We treated six AIDS patients who had cryptosporidiosis; for four patients, diagnosis was made by examination of stool specimens, for two patients by biopsy of the small bowel.</description><subject>AIDS</subject><subject>AIDS-Related Opportunistic Infections - complications</subject><subject>AIDS-Related Opportunistic Infections - drug therapy</subject><subject>Correspondence</subject><subject>Cryptosporidiosis</subject><subject>Cryptosporidiosis - complications</subject><subject>Cryptosporidiosis - drug therapy</subject><subject>Diarrhea</subject><subject>Humans</subject><subject>Paromomycin - administration &amp; dosage</subject><subject>Paromomycin - adverse effects</subject><subject>Paromomycin - therapeutic use</subject><subject>Vertigo - chemically induced</subject><subject>Weight loss</subject><issn>1058-4838</issn><issn>1537-6591</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1993</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kE1LAzEQhoMoWqs_QFDYk7e1mc3mY4-lWisIVmxBvIRsNovRblOTFO2_N6Wlpxnmed85PAhdAb4DXJGBXtilbcIA-B1LF46PUA8o4TmjFRynHVORl4KIM3QewhfGAALTU3QqgAHhtIde5sFkrs2myrvOdRttl1nrfBY_TTbzRsXOLOM2MPKbVXRh5bxtrAs2ZCk5VdEmHrJfGz-z4dP92wU6adUimMv97KP5-GE2muTPL49Po-FzrolgMaea66IQJWOaKChAMFHTpqIlrjWAEa2ui1poraBpGOcECNG8YkXDecVJW5I-ut39XXn3szYhys4GbRYLtTRuHSQwXmHBixSEXVB7F4I3rVx52ym_kYDlVqLcS5TAJZNbialzs3--rjvTHBp7a4lf7_hXiM4fcFlSTguScL7DNkTzd8DKf0vGU19O3j_krCQjqF4_5Jj8A4Ofhww</recordid><startdate>19931201</startdate><enddate>19931201</enddate><creator>Wallace, Mark R.</creator><creator>Nguyen, Minh-Thu</creator><creator>Newton, James A.</creator><general>The University of Chicago Press</general><general>University of Chicago Press</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>M7N</scope></search><sort><creationdate>19931201</creationdate><title>Use of Paromomycin for the Treatment of Cryptosporidiosis in Patients with AIDS</title><author>Wallace, Mark R. ; Nguyen, Minh-Thu ; Newton, James A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c386t-5c7c228466c3a121868b5d9540bc11e8fcb2b8cca1dd6773133c7962d77973f43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1993</creationdate><topic>AIDS</topic><topic>AIDS-Related Opportunistic Infections - complications</topic><topic>AIDS-Related Opportunistic Infections - drug therapy</topic><topic>Correspondence</topic><topic>Cryptosporidiosis</topic><topic>Cryptosporidiosis - complications</topic><topic>Cryptosporidiosis - drug therapy</topic><topic>Diarrhea</topic><topic>Humans</topic><topic>Paromomycin - administration &amp; dosage</topic><topic>Paromomycin - adverse effects</topic><topic>Paromomycin - therapeutic use</topic><topic>Vertigo - chemically induced</topic><topic>Weight loss</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wallace, Mark R.</creatorcontrib><creatorcontrib>Nguyen, Minh-Thu</creatorcontrib><creatorcontrib>Newton, James A.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><jtitle>Clinical infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wallace, Mark R.</au><au>Nguyen, Minh-Thu</au><au>Newton, James A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Use of Paromomycin for the Treatment of Cryptosporidiosis in Patients with AIDS</atitle><jtitle>Clinical infectious diseases</jtitle><addtitle>Clinical Infectious Diseases</addtitle><date>1993-12-01</date><risdate>1993</risdate><volume>17</volume><issue>6</issue><spage>1070</spage><epage>1071</epage><pages>1070-1071</pages><issn>1058-4838</issn><eissn>1537-6591</eissn><abstract>We read with interest the recent article by Fichtenbaum et al. on the use of paromomycin for the treatment of cryptosporidiosis in patients with AIDS. Our experiences with this agent also have been largely favorable, but long-term administration has often been required. We treated six AIDS patients who had cryptosporidiosis; for four patients, diagnosis was made by examination of stool specimens, for two patients by biopsy of the small bowel.</abstract><cop>United States</cop><pub>The University of Chicago Press</pub><pmid>8161375</pmid><doi>10.1093/clinids/17.6.1070</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1058-4838
ispartof Clinical infectious diseases, 1993-12, Vol.17 (6), p.1070-1071
issn 1058-4838
1537-6591
language eng
recordid cdi_proquest_miscellaneous_16790872
source Jstor Complete Legacy; MEDLINE; Oxford University Press Journals Digital Archive Legacy
subjects AIDS
AIDS-Related Opportunistic Infections - complications
AIDS-Related Opportunistic Infections - drug therapy
Correspondence
Cryptosporidiosis
Cryptosporidiosis - complications
Cryptosporidiosis - drug therapy
Diarrhea
Humans
Paromomycin - administration & dosage
Paromomycin - adverse effects
Paromomycin - therapeutic use
Vertigo - chemically induced
Weight loss
title Use of Paromomycin for the Treatment of Cryptosporidiosis in Patients with AIDS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T07%3A03%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Use%20of%20Paromomycin%20for%20the%20Treatment%20of%20Cryptosporidiosis%20in%20Patients%20with%20AIDS&rft.jtitle=Clinical%20infectious%20diseases&rft.au=Wallace,%20Mark%20R.&rft.date=1993-12-01&rft.volume=17&rft.issue=6&rft.spage=1070&rft.epage=1071&rft.pages=1070-1071&rft.issn=1058-4838&rft.eissn=1537-6591&rft_id=info:doi/10.1093/clinids/17.6.1070&rft_dat=%3Cjstor_proqu%3E4457523%3C/jstor_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16790872&rft_id=info:pmid/8161375&rft_jstor_id=4457523&rfr_iscdi=true